Search

everythinglearnresearchcommunity

for

Search:↓

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Metformin is less effective in men with early-onset hair loss.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Men with male pattern baldness may have a higher risk of heart problems.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Lichen planus may be associated with a higher risk of metabolic syndrome.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

SLE and DM can coexist but are rare and need careful evaluation.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.